Decomposition of organic peroxides and hydrogen peroxide by the iron thiolates and related complexes

US11242296B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11242296-B2
Application numberUS-201916514423-A
CountryUS
Kind codeB2
Filing dateJul 17, 2019
Priority dateJul 18, 2018
Publication dateFeb 8, 2022
Grant dateFeb 8, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed herein is a method of reducing or disproportionating peroxide, comprising combining an organic chalcogenide, an iron salt, and the peroxide in the presence of an additional reductant, which can be the organic chalcogenide. The method can be used to, e.g., prepare alcohols from peroxides and to disproportionate hydrogen peroxide into water and oxygen.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of decomposing a peroxide of Formula I: R 1 —O—O—R 2   (Formula I) wherein: each of R 1 and R 2 is independently selected from the group consisting of: (i) hydrogen; (ii) C 1-10 alkyl optionally substituted with 1-4 R a ; (iii) C 3-10 alkenyl optionally substituted with 1-4 R a ; (iv) C 3-10 alkynyl optionally substituted with 1-4 R a ; (v) C 6-10 aryl optionally substituted with 1-4 R a ; (vi) 5-10 membered heteroaryl including 5-10 ring atoms, wherein 1-4 ring atoms are each independently selected from the group consisting of N, NH, O, and S, wherein the heteroaryl is optionally substituted with 1-4 R a ; (vii) C 3-10 cycloalkyl that is optionally substituted with 1-4 R a ; (vii) 5-10 membered heterocyclyl including 3-10 ring atoms, wherein 1-3 ring atoms are each independently selected from the group consisting of N, NH and O, wherein the heterocyclyl is optionally substituted with 1-4 R a ; (viii) —C(O)R b ; (ix) —CO 2 R b ; (x) —Si(R′) 3 ; each occurrence of R a is independently selected from the group consisting of: (i) C 1-8 alkyl substituted with 1-3 R b ; (ii) (C 0-6 alkylene)-C 3-10 cycloalkyl, wherein the cycloalkyl is optionally substituted with from 1-4 R b ; (iii) (C 0-6 alkylene)-heterocyclyl including 3-10 ring atoms, wherein 1-3 ring atoms are each independently selected from the group consisting of NH, O, and S, wherein the heterocyclyl is optionally substituted with 1-4 R b ; (iv) (C 0-6 alkylene)-(C 6-10 aryl), wherein the aryl is optionally substituted with 1-5 R b ; or (v) (C 0-6 alkylene)-heteroaryl including 5-10 ring atoms, wherein 1-4 ring atoms are each independently selected from the group consisting of N, NH, O, and S, wherein the heteroaryl is optionally substituted with 1-3 R b ; (vi) C 1-4 alkoxy optionally substituted with 1-3 R b ; (vii) C 1-4 haloalkoxy; (viii) —COH; (ix) —CO 2 R b ; (x) —CONR b R b ; (xi) cyano; (xii) —NR b R b ; (xiii) —NR b C(O)NR b R b ; (xiv) —NR b C(O)OR b ; (xv) —NR b C(O)R b ; (xvi) C 1-4 thioalkoxy; (xvii) —N 3 ; (xviii) —CO 2 H; (xix) —C(O)R b ; (xx) —SO 1-2 (R b ); (xxi) —O n P(O) n Y 2 , wherein n is independently 0 or 1, and wherein each Y is independently selected from —OR b and C 1-6 alkyl; (xxii) —O—O—R c ; (xxiii) —(O—O—CH 2 CH 2 ) m —O—OR′″, wherein m is an integer from 1-1000; and alternatively, any two R a , taken together with the atoms they are bonded to and any atoms that intervene the atoms they are bonded to, form a ring selected from: (i) a C 3-10 cycloalkyl, wherein the a C 3-10 cycloalkyl is optionally substituted with 1-6 R b ; (ii) a 5-10-membered heterocyclyl comprising 1-6 heteroatoms selected O, S, and N, wherein the heterocyclyl is optionally substituted with 1-6 R b ; (iii) a C 6-10 aryl, wherein the aryl is optionally substituted with 1-6 R b ; and (iv) a 5-10 membered heteroaryl comprising 1-6 heteroatoms selected O, S, and N, wherein the heteroaryl is optionally substituted with 1-6 R b ; and 5-10-membered heterocyclyl comprising 1-6 heteroatoms selected O, S, and N, wherein the heterocyclyl is optionally substituted with 1-6 R b ; each occurrence of R b is independently selected from the group consisting of: (i) halo; (ii) cyano; (iii) C 1-6 alkyl; (iv) C 2-6 alkenyl; (v) C 2-6 alkynyl; (vi) C 1-4 haloalkyl; (vii) C 1-4 alkoxy; (viii) C 1-4 haloalkoxy; (ix) —(C 0-3 alkylene)-C 3-6 cycloalkyl optionally substituted with 1-4 independently selected C 1-4 alkyl; (x) —(C 0-3 alkylene)-heterocyclyl including 3-10 ring atoms, wherein 1-3 ring atoms are each independently selected from the group consisting of NH, O, and S, wherein the heterocyclyl is optionally substituted with 1-4 independently selected C 1-4 alkyl; (xi) —(C 0-3 alkylene)-phenyl; (xii) —(C 0-3 alkylene)-heteroaryl including 5-10 ring atoms, wherein 1-4 ring atoms are each independently selected from the group consisting of N, NH, O, and S; (xiii) —S(O) 1-2 (C 1-4 alkyl); and (xiv) —NR′R″; (xv) —OH; (xvi) —S(O) 1-2 (NR′R″); (xvii) —C 1-4 thioalkoxy; (xviii) —NO 2 ; (xix) —N(R′)(C(═O)C 1-3 alkyl); (xx) —C(═O)(C 1-4 alkyl); (xxi) —C(═O)O(C 1-4 alkyl); (xxii) —C(═O)OH, and (xxiii) —C(═O)N(R′)(R″); and alternatively, any two R b , taken together with the atoms they are bonded to and any atoms that intervene the atoms they are bonded to, form a ring selected from: (i) a C 3-10 cycloalkyl, wherein the a C 3-10 cycloalkyl is optionally substituted with 1-6 R d ; (ii) a 5-10-membered heterocyclyl comprising 1-6 heteroatoms selected O, S, and N, wherein the heterocyclyl is optionally substituted with 1-6 R d ; (iii) a C 6-10 aryl, wherein the aryl is optionally substituted with 1-6 R d ; and (iv) a 5-10 membered heteroaryl comprising 1-6 heteroatoms selected O, S, and N, wherein the heteroaryl is optionally substituted with 1-6 R d ; and 5-10-membered heterocyclyl comprising 1-6 heteroatoms selected O, S, and N, wherein the heterocyclyl is optionally substituted with 1-6 R d ; each occurrence of R c is independently selected from the group consisting of: (i) hydrogen; (ii) C 1-10 alkyl optionally substituted with 1-4 R d ; (iii) C 3-10 alkenyl optionally substituted with 1-4 R d ; (iv) C 3-10 alkynyl optionally substituted with 1-4 R d ; (v) C 6-10 aryl optionally substituted with 1-4 R d ; (vi) 5-10 membered heteroaryl including 5-10 ring atoms, wherein 1-4 ring atoms are each independently selected from the group consisting of N, NH, O, and S, wherein the heteroaryl is optionally substituted with 1-4 R d ; (vii) C 3-10 cycloalkyl that is optionally substituted with 1-4 R d ; (vii) 5-10 membered heterocyclyl including 3-10 ring atoms, wherein 1-3 ring atoms are each independently selected from the group consisting of N, NH and O, wherein the heterocyclyl is optionally substituted with 1-4 R d ; (viii) —C(O)R b ; (ix) —CO 2 R b ; and (x) —Si(R′) 3 ; each occurrence of R d is independently selected from the group consisting of: (i) C 1-8 alkyl substituted with 1-3 R b ; (ii) (C 0-6 alkylene)-C 3-10 cycloalkyl, wherein the cycloalkyl is optionally substituted with from 1-4 R b ; (iii) (C 0-6 alkylene)-heterocyclyl including 3-10 ring atoms, wherein 1-3 ring atoms are each independently selected from the group consisting of NH, O, and S, wherein the heterocyclyl is optionally substituted with 1-4 R b ; (iv) (C 0-6 alkylene)-(C 6-10 aryl), wherein the aryl is optionally substituted with 1-5 R b ; or (v) (C 0-6 alkylene)-heteroaryl including 5-10 ring atoms, wherein 1-4 ring atoms are each independently selected from the group consisting of N, NH, O, and S, wherein the heteroaryl is optionally substituted with 1-3 R b ; (vi) C 1-4 alkoxy optionally substituted with 1-3 R b ; (vii) C 1-4 haloalkoxy; (viii) —COH; (ix) —CO 2 R b ; (x) —CONR b R b ; (xi) cyano; (xii) —NR b R b ; (xiii) —NR b C(O)NR b R b ; (xiv) —NR b C(O)OR b ; (xv) —NR b C(O)R b ; (xvi) C 1-4 thioalkoxy; (xvii) —N 3 ; (xviii) —CO 2 H; (xix) —C(O)R b ; (xx) —SO 1-2 (R b ); and (xxi) —O n P(O) n Y 2 , wherein n is independently 0 or 1, and wherein each Y is independently selected from —OR b and C 1-6 alkyl; and each occurrence of R′, R″, and R′″ is independently selected from the group consisting of: H, C 1-4 alkyl, and phenyl; or, if R′ and R″ are bonded to the same atom, R′ and R″ together with the atom to which each is attached forms a ring including 3-8 ring atoms, wherein the ring includes: (a) 1-7 ring carbon atoms; and (b) 0-3 ring heteroatoms (in addition to the atom attached to R′ and R″), which are each independently selected from the group consisting of N, NH, O, and S; alternatively, R 1 and R 2 , taken together with the oxygen atoms they are bonded to, form a 5-10-membered heterocyclyl comprising 1-6 heter

Assignees

Inventors

Classifications

  • C07B41/02Primary

    of hydroxy or O-metal groups · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11242296B2 cover?
Disclosed herein is a method of reducing or disproportionating peroxide, comprising combining an organic chalcogenide, an iron salt, and the peroxide in the presence of an additional reductant, which can be the organic chalcogenide. The method can be used to, e.g., prepare alcohols from peroxides and to disproportionate hydrogen peroxide into water and oxygen.
Who is the assignee on this patent?
Nutech Ventures
What technology area does this patent fall under?
Primary CPC classification C07B41/02. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).